FrancophonIA/ELRC3.0 huggingface dataset:
English: Nervous system symptoms may include memory lapse; speech and communication difficulties; a change in your mood or behaviour; confusion or inability to control your muscles; weakness on one side of the body; vision changes; or headache.
Danish: Symptomer fra nervesystemet kan omfatte hukommelsestab; tale- og kommunikationsbesvær; ændret humør eller adfærd; forvirring eller manglende muskelkontrol; svaghed i den ene side af kroppen; synsforandringer eller hovedpine.
English: Any disease of the brain causing headache, fever, hallucinations, confusion, abnormal speech and body movement
Danish: Hjernesygdomme som forårsager hovedpine, feber, hallucinationer, forvirring, taleforstyrrelser og unormale kropsbevægelser
English: End of Week 8 and Week 12 after transplantation
Danish: Slutningen af uge 8 og uge 12 efter transplantation
English: NULOJIX is supplied in a 20 ml vial (Type I flint glass) with a stopper (20 mm grey butyl rubber) and flip off seal (aluminum).
Danish: NULOJIX fås i et 20 ml hætteglas (Type 1 flintglas) med prop (20 mm grå butylgummi) og forsegling (aluminium), der kan vippes af.
English: The overall proportion of patients with death or graft loss was comparable across treatment groups (29.3%, 30.9%, and 28.3% for MI, LI and ciclosporin, respectively) in Study 2.
Danish: Den samlede andel af patienter, der døde eller mistede transplantatet, var sammenlignelig for alle behandlingsgrupper (29,3 %, 30,9 % og 28,3 % for hhv. MI, LI og ciclosporin) i Studie 2.
English: Number of vials required equals the belatacept dose in mg divided by 250 rounded up to the next full number of vials.
Danish: Det krævede antal hætteglas svarer til belatacept-dosis i mg divideret med 250, som rundes op til nærmeste hele antal hætteglas.
English: Table 2: Adverse reactions in clinical trials Infections and infestations Very Common urinary tract infection, upper respiratory infection, cytomegalovirus infection*, bronchitis
Danish: Tabel 2: Bivirkninger i kliniske studier Infektioner og parasitære sygdomme Meget almindelig urinvejsinfektion, infektion i øvre luftveje, cytomegalovirusinfektion*, bronkitis
English: As compared to ciclosporin and assessed by the hazard ratio (HR) estimates (for death or graft loss) from an ad hoc Cox regression analysis, overall patient and graft survival was higher for belatacepttreated patients in Study 1, HR 0.588 (95% CI: 0.356-0.972) for the MI group and HR 0.585 (95% CI: 0.356-0.961) for the LI group, and comparable across treatment groups in Study 2, HR 0.932 (95% CI: 0.635-1.367) for the MI group and HR 0.944 (95% CI: 0.644-1.383) for the LI group.
Danish: Sammenlignet med ciclosporin og vurderet efter estimater for hazard ratio (HR) (for død eller tab af transplantat) fra en ad hoc Cox regressionsanalyse var den samlede patient- og transplantatoverlevelse højere for belataceptbehandlede patienter i Studie 1, HR 0,588 (95 % CI: 0,356-0,972) for MI-gruppen og HR 0,585 (95 % CI: 0,356-0,961) for LI-gruppen, og var sammenlignelig for alle behandlingsgrupper i Studie 2, HR 0,932 (95 % CI: 0,635-1,367) for MI-gruppen og HR 0,944 (95 % CI: 0,644-1,383) for LI-gruppen.
English: If any serious allergic or anaphylactic reaction occurs, NULOJIX therapy should be discontinued immediately and appropriate therapy initiated.
Danish: Hvis der opstår alvorlige allergiske eller anafylaktiske reaktioner, bør behandlingen med NULOJIX straks afbrydes og adækvat behandling iværksættes.
English: Dose modification of NULOJIX is not recommended for a change in body weight of less than
Danish: Dosisjustering af NULOJIX frarådes ved en ændring af kropsvægt på under 10%.
English: Serious infections Serious infections can happen with NULOJIX treatment and can lead to death.
Danish: Alvorlige infektioner I forbindelse med NULOJIX-behandling kan der opstå alvorlige infektioner, der kan være dødelige.
English: No dose adjustment is recommended in patients with renal impairment or undergoing dialysis (see section 5.2).
Danish: Dosisjustering anbefales ikke hos patienter med nyreinsufficiens eller patienter, der er i dialyse (se pkt.
English: What you need to know before you use NULOJIX 3.
Danish: Det skal du vide, før du begynder at bruge NULOJIX 3.
English: No patients with hepatic impairment were studied in renal transplant protocols, therefore dose modification of belatacept in hepatic impairment can not be recommended.
Danish: Der indgik ikke nogen patienter med leverinsufficiens i nyretransplantationsprotokoller og derfor kan der ikke gives anbefalinger om dosisjustering af belatacept i tilfælde af leverinsufficiens.
English: OTHER SPECIAL WARNING(S), IF NECESSARY Only use co-packed syringe for reconstitution and dilution.
Danish: EVENTUELLE ANDRE SÆRLIGE ADVARSLER Brug kun medfølgende engangssprøjte til rekonstituering og fortynding.
English: Prior to administration, the solution for infusion should be inspected visually for particulate matter or discolouration.
Danish: Inden administration skal infusionsvæsken efterses for partikelholdigt materiale og misfarvning.
English: Animal studies do not indicate direct or indirect harmful effects with respect to embryonal/foetal development at doses up to 16-fold and 19-fold a human 10 mg/kg dose based on AUC.
Danish: Dyreforsøg tyder ikke på direkte eller indirekte uønsket effekt på den embryonale/føtale udvikling ved doser på op til 16 og 19 gange den humane dosis på 10 mg/kg baseret på AUC.
English: In Study 2, in the MI, LI, and ciclosporin groups, respectively, death occurred in 20.1%, 21.1%, and 15.8% of patients, and graft loss occurred in 11.4%, 13.1%, and 15.8% of patients.
Danish: I Studie 2, i hhv. MI-, LI- og ciclosporingrupperne, forekom der dødsfald hos 20,1 %, 21,1 % og 15,8 % af patienterne, og der forekom tab af transplantat hos 11,4 %, 13,1 % og 15,8 % af patienterne.
English: In postmarketing experience in patients with other predisposing risk factors for thrombosis of the renal allograft, renal allograft thrombosis has occurred when the initial dose of anti-thymocyte globulin, as immunosuppressive induction, was coadministered at the same or nearly the same time with the first dose of belatacept.
Danish: Erfaring efter markedsføring har vist, at der er forekommet renal allotransplantat trombose hos patienter med andre prædisponerende risikofaktorer for trombose i det renale allotransplantat, når initialdosis af anti-thymocytglobulin, som immunosuppressiv induktion, blev administreret på samme tid eller næsten samme tid som den første dosis af belatacept (se pkt.
English: Uncommon abnormal dreams, mood swings, attention deficit/hyperactivity disorder, libido increased
Danish: Ikke almindelig unormale drømme, humørsvingninger, nedsat koncentration/hyperaktivitet, øget libido
English: The median age was 45 years; 58% of donor organs were from living patients; 3% were re-transplanted; 69% of the study population was male; 61% of patients were white, 8% were black/African-American, 31% were categorised as of other races; 16% had PRA  10%; and 41% had 4 to 6 HLA mismatches.
Danish: Gennemsnitsalderen var 45 år; 58% af donororganerne var fra levende patienter; 3% var retransplanterede; 69% af studiepopulationen var mænd; 61% af patienterne var hvide, 8% var sorte/afroamerikanere, 31% blev kategoriseret som andre racer; 16% havde PRA ≥ 10%, og 41% havde 4-6 mismatch på HLA.
English: In the 3 studies (one Phase 2 and two Phase 3 studies, Study 1 and Study 2), the cumulative frequency of PTLD was higher in belatacept treated patients at the recommended dosing regimen (LI) (1.3%; 6/472) than in the ciclosporin group (0.6%; 3/476), and was highest in the belatacept MI group (1.7%; 8/477).
Danish: I de 3 studier (et fase 2- og to fase 3-studier, Studie 1 og Studie 2) var den kumulative hyppighed af PTLD højere hos belatacept-behandlede patienter ved den anbefalede dosering (LI) (1,3%; 6/472) end i ciclosporin-gruppen (0,6%; 3/476) og den var højest i belatacept MI-gruppen (1,7%; 8/477).
English: Concomitant use with other immunosuppressive agents Belatacept has been administered with the following immunosuppressive agents in clinical studies: basiliximab, an MPA and corticosteroids.
Danish: Betalacept er blevet administreret med følgende immunsuppressiva i kliniske studier: basiliximab, en MPA og kortikosteroider.
English: Insert the syringe needle into the vial through the centre of the rubber stopper.
Danish: Før nålen gennem midten af gummiproppen.
English: During clinical studies, there was no dose modification of belatacept for a change in body weight of less than 10%.
Danish: I kliniske studier var der ingen dosisjustering af belatacept ved ændringer i kropsvægten på under
English: Corticosteroid Taper: Corticosteroid tapering in patients taking belatacept should be implemented cautiously, particularly in patients at high immunologic risk, such as those with 4 to 6 human leukocyte antigen (HLA) mismatches.
Danish: Nedtrapning af kortikosteroider: Nedtrapning af kortikosteroid hos patienter, der får belatacept, bør foregå med forsigtighed, især hos patienter med 4-6 mismatch på humant leukocyt-antigen (HLA).
English: The powder is a white to off-white whole or fragmented cake.
Danish: Pulveret er hvidt til råhvidt i en hel eller fragmenteret blok.
English: Belatacept was not teratogenic when administered to pregnant rats and rabbits at doses up to 200 mg/kg and 100 mg/kg daily, respectively, representing approximately 16 and 19 times the exposure associated with the maximum recommended human dose (MRHD) of 10 mg/kg based on AUC.
Danish: Belatacept var ikke teratogen, når det blev administreret til drægtige rotter og kaniner ved doser på op til henholdsvis 200 mg/kg og 100 mg/kg dagligt, hvilket udgjorde ca. 16 og 19 gange eksponeringen for den maksimalt anbefalede humane dosis på 10 mg/kg baseret på AUC.
English: In a pre- and postnatal development study in rats, limited changes in immune function were observed at 19-fold a human 10 mg/kg dose based on AUC (see section 5.3).
Danish: Der er i et præ- og postnatalt udviklingsstudie med rotter observeret begrænsede forandringer i immunfunktionen ved en dosis på 19 gange den humane dosis på 10 mg/kg, baseret på AUC (se pkt.
English: Study 1 excluded (1) recipients undergoing a first transplant whose current PRA were ≥50%; (2) recipients undergoing a retransplantation whose current PRA were ≥30%; (3) recipients when previous graft loss was due to acute rejection and in case of a positive T-cell lymphocytotoxic cross match.
Danish: Studie 1 ekskluderede (1) modtagere, som gennemgik deres første transplantation, og hvis eksisterende Panel Reactive Antibodies (PRA) var ≥50%, (2) modtagere, som gennemgik en retransplantation, og hvis eksisterende PRA var ≥30%, (3) modtagere, hvis tidligere grafttab skyldtes akut afstødning og i tilfælde af positiv T-celle lymfocytotoksisk crossmatch.
English: If any serious allergic or anaphylactic reaction occurs, belatacept therapy should be discontinued immediately and appropriate therapy initiated (see section 4.4).
Danish: Hvis der forekommer alvorlige allergiske eller anafylaktiske reaktioner, bør behandling med belatacept straks seponeres og adækvat behandling påbegyndes (se pkt.
English: A total of 321 belatacept (MI: 155 and LI: 166) and 136 ciclosporin patients completed 3 years of treatment in Study 1 and entered the 4-year long-term open label extension period (up to 7 years in total).
Danish: I alt 321 patienter i belataceptgrupperne- (MI: 155 og LI: 166) og 136 patienter i ciclosporingruppen gennemførte 3 års behandling i Studie 1 og fortsatte i den 4-årige, åbne langtidsopfølgningsperiode (op til 7 år i alt).
English: NULOJIX should be administered in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids.
Danish: NULOJIX bør administreres i kombination med basiliximab-induktion, mycophenolatmofetil og kortikosteroider.
English: It is not known whether belatacept, the active substance, passes into human milk.
Danish: Det vides ikke om det aktive stof belatacept udskilles i modermælk.
English: Belatacept-treated transplant recipients who are EBV seronegative are at an increased risk for PTLD compared with those who are EBV positive (see section 4.8).
Danish: Belatacept-behandlede transplantationspatienter, som er EBV-seronegative, har en øget risiko for PTLD sammenlignet med de transplantationspatienter, der er EBV-positive (se pkt.
English: If you are allergic to belatacept or any of the other ingredients of the medicine (listed in section 6).
Danish: Brug ikke NULOJIX hvis du er allergisk over for belatacept eller et af de øvrige indholdsstoffer i dette lægemiddel (angivet i punkt 6).
English: Corticosteroid tapering in patients taking belatacept should be implemented cautiously, particularly in patients with 4 to 6 human leukocyte antigen (HLA) mismatches (see sections 4.4 and 5.1)
Danish: Nedtrapning af kortikosteroid hos patienter, der får belatacept, bør foregå med forsigtighed, især hos patienter med 4-6 mismatch på humant leukocyt-antigen (HLA) (se pkt.
English: Volume of the reconstituted solution required (ml) equals total belatacept dose in mg divided by 25.
Danish: Den nødvendige mængde rekonstitueret opløsning (ml) fås ved at dividere den totale belataceptdosis i mg med 25.
English: Belatacept is therefore not expected to affect cytochrome P450 enzymes via effects on cytokines.
Danish: Derfor forventes belatacept ikke at påvirke CYP-enzymer via cytokinpåvirkning.
English: Study 1: Recipients of Living Donor and Standard Criteria Deceased Donor Kidneys Standard criteria donor organs were defined as organs from a living donor, or a deceased donor with anticipated cold ischemia time of < 24 hours and not meeting the definition of extended criteria donor organs.
Danish: Donororganer efter standardkriterier blev defineret som organer fra en levende donor eller en afdød donor med forventet kold iskæmi-tid på < 24 timer, som ikke kunne defineres som extended criteria donororganer.
English: The mean (range) pharmacokinetic parameters of belatacept after multiple intravenous infusions at doses of 5 and 10 mg/kg in renal transplant subjects were: terminal half-life, 8.2 (3.1-11.9) and 9.8 (6.1-15.1) days, respectively; systemic clearance 0.51 (0.33-0.75) and 0.49 (0.23-0.70) ml/h/kg, respectively; and distribution volume at steady state, 0.12 (0.09-0.17) and 0.11 (0.067-0.17) l/kg, respectively.
Danish: Middelværdierne (intervallet) farmakokinetiske parametre for belatacept efter flere intravenøse infusioner med doser på 5 og 10 mg/kg til nyretransplantationspatienter var: terminal halveringstid henholdsvis 8,2 (3,1-11,9) og 9,8 (6,1-15,1) dage; systemisk clearance henholdsvis 0,51 (0,33-0,75) og 0,49 (0,23-0,70) ml/h/kg og fordelingsvolumen ved steady state henholdsvis 0,12 (0,09-0,17) og 0,11 (0,067-0,17) l/kg.
English: Fewer patients met the composite renal impairment endpoint and mean GFR was higher with belatacept compared to ciclosporin.
Danish: Færre patienter med belatacept end med ciclosporin nåede det sammensatte endepunkt nedsat nyrefunktion og gennemsnitlig GFR var højere med belatacept end med ciclosporin.
English: Total dose of belatacept in mg equals the patient weight in kg times the belatacept dose in mg/kg (5 or 10 mg/kg, see section 4.2).
Danish: Den totale belatacept-dosis i mg svarer til patientens vægt i kg gange belatacept-dosis i mg/kg (5 eller 10 mg/kg, se afsnit 3).
English: aProportion of Patients with Measured GFR < 60 ml/min/1.73 m2 or with a Decrease in Measured GFR ≥ 10 ml/min/1.73 m2 from Month 3 to Month 12. b Measured GFR was assessed by iothalamate at Year 1 and 2 only c Calculated GFR was assessed by MDRD formula at Month 1, Years 1, 2, and 3
Danish: a Andel af patienter med målt GFR < 60 ml/min/1,73 m2 eller med fald i målt GFR ≥ 10 ml/min/1,73 m2 fra måned 3 til måned 12. b Målt GFR blev bestemt ved iothalamat udelukkende ved år 1 og 2 c Beregnet GFR blev beregnet ved MDRD-formlen ved måned 1, år 1, 2 og 3
English: Overall occurrences of polyoma virus infections and fungal infections were numerically lower in the belatacept LI group compared with the belatacept MI and ciclosporin groups.
Danish: Den samlede hyppighed af polyomavirusinfektion og svampeinfektioner var numerisk lavere i belatacept LI-gruppen end i belatacept MI- og ciclosporin-gruppen.
English: At Month 1, 4, and 6 post-transplant, the mean (range) trough concentrations of belatacept were 22.7 (11.1-45.2), 7.6 (2.1-18.0), and 4.0 (1.5-6.6) μg/ml, respectively.
Danish: Ved måned 1, 4 og 6 efter transplantation var middelværdien (intervallet) for laveste koncentrationer af belatacept henholdsvis 22,7 (11,1-45,2), 7,6 (2,1-18,0) og 4,0 (1,5-6,6) µg/ml.
English: The other case of PML was reported in a liver transplant recipient in a Phase 2 trial who received 6 months of treatment with an augmented belatacept MI regimen, MMF at doses higher than the recommended dose and corticosteroids (see section 4.4).
Danish: Det andet tilfælde af PML blev rapporteret i et fase 2-forsøg hos en levertransplantatrecipient, som fik 6 måneders behandling med et forhøjet belatacept MI-regime, MMF ved doser højere end det anbefalede og kortikosteroider (se pkt.
English: One fatal case of PML was reported in a renal transplant recipient treated with belatacept MI regimen, an IL-2 receptor antagonist, MMF, and corticosteroids for 2 years in a Phase 3 trial.
Danish: Et fatalt tilfælde af PML blev rapporteret hos en nyretransplantatrecipient, der blev behandlet med belatacept MI-regime, en IL-2-receptorantagonist, MMF og kortikosteroider i 2 år i et fase 3-forsøg.
English: If you are given more NULOJIX than you should If this happens, your doctor will monitor you for any signs or symptoms of side effects, and treat these symptoms if necessary.
Danish: Hvis dette sker, vil lægen undersøge dig for tegn og symptomer på bivirkninger og om nødvendigt behandle dig for eventuelle symptomer.
English: In a prespecified pooled analysis of Studies 1 and 2 at Year 1, the incidence of new onset diabetes mellitus (NODM), defined as use of an antidiabetic agent for ≥ 30 days or ≥ 2 fasting plasma glucose values > 126 mg/dl (7.0 mmol/l) post-transplantation, was 5% with belatacept and 10% with ciclosporin.
Danish: I en præ-defineret poolet analyse af studie 1 og 2 ved år 1 var hyppigheden for nyopstået diabetes mellitus (NODM), defineret som brug af antidiabetika i ≥ 30 dage eller ≥ 2 fastende plasmaglucoseværdier > 126 mg/dl (7,0 mmol/l) efter transplantation, 5% med belatacept og 10% med ciclosporin.
English: You must stop breast-feeding if you are being treated with NULOJIX.
Danish: Du skal stoppe med at amme, hvis du er i behandling med NULOJIX.
English: The pharmacokinetics of belatacept in renal transplant patients and healthy subjects appeared to be comparable.
Danish: Belatacepts farmakokinetik hos nyretransplantationspatienter og raske forsøgspersoner viste sig at være sammenlignelig.
English: In addition to PTLD, patients receiving immunosuppressive regimens, including belatacept, are at increased risk of malignancies, including skin cancer (see section 4.8).
Danish: Patienter, der får immunsuppressiv behandling, inklusiv belatacept, har udover en øget risiko for PTLD en øget risiko for maligniteter inklusiv hudcancer (se pkt.
English: Use the silicone-free disposable syringe provided to make up the vials and to add the solution to the infusion.
Danish: Anvend den medfølgende silikonefrie engangssprøjte til at klargøre hætteglassene og tilsætte opløsningen til infusionen.
English: These Grade III rejections occurred in patients with 4 to 6 HLA mismatches (see sections 4.2 and 5.1).
Danish: Disse grad III-afstødninger forekom hos patienter med 4-6 mismatch på HLA (se pkt.
English: Pack sizes: 1 vial and 1 syringe or 2 vials and 2 syringes.
Danish: Pakningsstørrelser: 1 hætteglas og 1 sprøjte eller 2 hætteglas og 2 sprøjter.
English: This medicine contains 0.65 mmol (or 15 mg) sodium per vial which corresponds to 1.95 mmol (or 45 mg) sodium per maximum dose of three vials.
Danish: Denne medicin indeholder 0,65 mmol (eller 15 mg) natrium pr. hætteglas, hvilket svarer til 1,95 mmol (eller 45 mg) natrium per maksimumsdosis fra 3 hætteglas.
English: The solution for infusion may be stored for a maximum of 4 hours of the total 24 hours below 25°C.
Danish: Infusionsvæsken kan opbevares i højst 4 ud af de 24 timer ved under 25°C.
English: A total of 217 belatacept (MI: 104 and LI: 113) and 87 ciclosporin patients completed 3 years of treatment in Study 2 and entered the 4-year long-term open label extension period (up to 7 years in total).
Danish: I alt 217 patienter i belataceptgrupperne- (MI: 104 og LI: 113) og 87 patienter i ciclosporingruppen gennemførte 3 års behandling i Studie 2 og fortsatte i den 4-årige, åbne langtidsopfølgningsperiode (op til 7 år i alt).
English: Low blood count or anaemia, low white blood cell count Increased amounts of creatinine in your blood (blood test used to measure kidney function), increased amounts of protein in your urine
Danish: Ændret blodbillede eller anæmi, lavt antal hvide blodlegemer Øget mængde kreatinin i blodet (der anvendes blodprøver for at måle nyrefunktionen), øget mængde protein i urinen
English: Disposal Any unused product or waste material should be disposed of in accordance with local requirements.
Danish: Bortskaffelse Ikke anvendte lægemidler samt affald heraf skal bortskaffes i henhold til lokale retningslinjer.
English: If you stop using NULOJIX
Danish: Hvis du holder op med at bruge NULOJIX
English: SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
Danish: EVENTUELLE SÆRLIGE FORHOLDSREGLER VED BORTSKAFFELSE AF IKKE ANVENDT LÆGEMIDDEL SAMT AFFALD HERAF Kasser eventuel ubrugt opløsning.
English: This corresponds to 1.95 mmol (or 45 mg) sodium per maximum dose of 3 vials.
Danish: Dette svarer til 1,95 mmol (eller 45 mg) natrium pr. maksimaldosis på 3 hætteglas.
English: Infusion-related reactions have been reported with belatacept administration in clinical studies.
Danish: Der er rapporteret om infusionsrelaterede reaktioner ved administration af belatacept i kliniske studier.
English: NULOJIX, in combination with corticosteroids and a mycophenolic acid (MPA), is indicated for prophylaxis of graft rejection in adults receiving a renal transplant (see section 5.1 for data on renal function).
Danish: NULOJIX er i kombination med kortikosteroider og en mycophenolsyre (MPA) indiceret til profylakse mod graftafstødning hos voksne nyretransplantationspatienter (se pkt.
English: If you forget to use NULOJIX
Danish: Hvis du har glemt at bruge NULOJIX
English: Abnormal swelling of the brain, increased pressure inside the skull and brain, seizure, weakness causing loss of movement on one side of the body, loss of the covering around nerves, inability of muscles to move in the face
Danish: Unormal hævelse i hjernen, øget tryk i kraniet og hjernen, krampeanfald, svækkelse som medfører lammelse i den ene side af kroppen, manglende nerveskeder, manglende muskelbevægelser i ansigtet
English: Fast heart rate, slow heart rate, abnormal and irregular heart beat, weak heart Diabetes
Danish: Hurtig hjerterytme, langsom hjerterytme, unormal og uregelmæssigt hjerterytme, svagt hjerte Sukkersyge
English: In Study 1, 5/39 belatacept patients versus 1/21 ciclosporin patients with AR had experienced graft loss, and 5/39 belatacept patients and no ciclosporin patients with AR had died by Year 3.
Danish: I studie 1 havde 5/39 belatacept-patienter versus 1/21 ciclosporin-patienter med AR oplevet transplantattab samt 5/39 belatacept-patienter og ingen ciclosporin-patienter med akut afstødning døde ved år 3.
English: Non-melanoma skin cancers occurred less frequently with the belatacept LI regimen than with the ciclosporin or belatacept MI regimens.
Danish: Non-melanom hudcancer forekom mindrehyppigt med belatacept LI-regimen end med cicloporin eller belatacept MI-regimen.
English: Chemical and physical in-use stability of the solution for infusion has been demonstrated for 24 hours when stored in a refrigerator (2°C - 8°C).
Danish: Der er vist kemisk og fysisk holdbarhed i 24 timer ved opbevaring i køleskab (2°C - 8°C).